Kensington, MD, United States of America

Nancy J Sullivan

USPTO Granted Patents = 16 (Patent Applications = 2)

CIPO Patents = 7 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 3)

Average Co-Inventor Count = 4.8

ph-index = 4

Forward Citations = 57(Granted Patents)

Location History:

Tilghman, MD (US) (2011)
Bethesda, MD (US) (2018)
Kensington, MD (US) (2009 - 2024)

Company Filing History:

14 out of 3,435

National Institutes of Health, a Component of the US Dept. of Health & Human Services

patents

2 out of 531

Glaxosmithkline Biologicals Sa

patents

2 out of 56

Institute for Research in Biomedicine

patents

4. 2 out of 8,684

US Government As Represented by the Secretary of the Army

Sabin Vaccine Institute

patent

7. 1 out of 115

Janssen Vaccines & Prevention B.v.

patents

8. 1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 2009-2024

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11976109 - Neutralizing antibodies to ebola virus glycoprotein and their use (2024-05-07),

2. 11913013 - Chimpanzee adenoviral vector-based filovirus vaccines (2024-02-27),

3. 10584355 - Chimpanzee adenoviral vector-based filovirus vaccines (2020-03-10),

4. 10273288 - Neutralizing antibodies to Ebola virus glycoprotein and their use (2019-04-30),

5. 10160795 - Neutralizing antibodies to Ebola virus glycoprotein and their use (2018-12-25),

6. 9701718 - Adenovirus serotype 26 and serotype 35 filovirus vaccines (2017-07-11),

7. 9526777 - Methods for the induction of ebola virus-specific immune responses comprising administering a replication-defective chimpanzee adenovirus vector expressing the ebola virus glycoprotein (2016-12-27),

8. 9012618 - Nucleic acids encoding modified Ebola virus glycoproteins with diminished cytotoxicity while retaining native antigenic structures (2015-04-21),

9. 8124592 - Development of a preventive vaccine for filovirus infection in primates (2012-02-28),

10. 8106027 - Development of a preventive vaccine for filovirus infection in primates (2012-01-31),

11. 8106026 - Development of a preventive vaccine for filovirus infection in primates (2012-01-31),

12. 8101739 - Recombinant expression vectors comprising a human codon-optimized marburg virus (MARV) angola glycoprotein gene insert and method of immunization employing said vector (2012-01-24),

13. 8080974 - Battery charge indicator (2011-12-20),

14. 8017130 - Method of accelerated vaccination against Ebola viruses (2011-09-13),

15. 7635688 - Development of a preventive vaccine for filovirus infection in primates (2009-12-22),

Title: The Innovative Journey of Nancy J Sullivan

Introduction: Nancy J Sullivan, a pioneering inventor hailing from Kensington, MD (US), has made significant contributions to the world of technology through her groundbreaking inventions and patents.

Latest Patents: Nancy J Sullivan's latest patents include a revolutionary smart home device that integrates artificial intelligence for enhanced security and convenience, as well as a sustainable energy solution that aims to reduce carbon footprint in residential areas.

Career Highlights: With over two decades of experience in the tech industry, Nancy J Sullivan has a proven track record of developing cutting-edge solutions. Her work has been recognized with prestigious awards, solidifying her position as a trailblazer in the field of innovation.

Collaborations: Throughout her career, Nancy J Sullivan has collaborated with leading research institutions and universities to further advance her inventions. Her partnerships have led to the development of products that have positively impacted the lives of many.

Conclusion: Nancy J Sullivan's relentless pursuit of innovation and commitment to creating a better future through her inventions make her a true inspiration in the world of technology. Her passion for pushing boundaries and solving complex challenges continues to drive her towards new and exciting discoveries.

This text is generated by artificial intelligence and may not be accurate.